Sven Olek and Berlin - Free people check

(1 - 17 from 17

)

Epiontis entwickelt neuen Immuntest - Innovations Report

www.innovations-report.de

Dr. Sven Olek Epiontis GmbH Berlin Dr. Christian Hammel TSB Technologiestiftung Berlin

Precision for Medicine Acquires Epiontis

www.bionity.com

Precision for Medicine, part of the Precision Medicine Group, announced today it has acquired Berlin-based Epiontis GmbH, a next-generation European specialty...

Precision For Medicine Significantly Expands Berlin Lab As ...markets.businessinsider.com › news › stocks › precision...

markets.businessinsider.com

Commenting on the importance of the new Berlin lab, Sven Olek, senior vice president and lab director explained, "For the first time ever, the ...

Health Discovery Corporation (HDVY): Where would HDVY go with a PR...

investorshub.advfn.com

Contact Sven Olek, PhD Epiontis GmbH Berlin, Germany Telefon: + Fax: +

HAPLO-IMMUNE | Transcan-2 translational cancer research program

www.transcanfp7.eu

Sven OLEK (Germany) Epiontis Gmbh, Berlin Antoine TOUBERT (France) Hopital Saint Louis, UMRS940, Paris Cedex Andrea VELARDI (Italy) Ospedale Santa Maria della ...

The Ratio of Regulatory (FOXP3 +) to Total (CD3 +) T Cells ...

www.sciencedirect.com

Sven Olek is an employee and owner of Epiontis, Berlin, a company that develops epigenetic assays. Janika Schulze and Katharina Gellhaus are employees of Epiontis, Berlin. Sven Olek holds patents on assays for the quantification of Foxp3 + and CD3 + T cells. The other authors declare that they have no competing financial interest.

Erratum to: Effects of aging on human leukocytes (part II ...link.springer.com › article

link.springer.com

Udo Baron; & Sven Olek. Deutsches Rheuma-Forschungszentrum – a Leibniz Institute, CharitéBerlin, Germany. Ulrik Stervbo ...

Sven Olek, Berlin DE - Patent applications

www.patentsencyclopedia.com

Patent application number Description Published; : Personalizing Cancer Chemotherapy Based on Methylation and Germ-Line Mutational Analysis of BRCA-1 - The

Precision for Medicine Acquires Leading Immune Monitoring And...

www.asianhhm.com

BETHESDA, Md. and BERLIN, Oct. 4, PRNewswire/ -- Precision for Medicine, part of the Precision Medicine Group, announced today it has acquired...

Emed - SP 9

www.sys-med.de

determination. Contact. Dr. Sven Olek. Epiontis GmbH Berlin. Sven.olek@ epiontis.com.

Olek, Berlin - Patent applications

www.patentsencyclopedia.com

Sven Olek, Berlin DE. Patent application number of the invention Patent applications by Sven Olek, Berlin DE. Website © Advameg, Inc.

Precision for Medicine Significantly Expands Berlin Lab as Demand For...

onenucleus.com

NEW STATE-OF-THE-ART FACILITY DRAMATICALLY INCREASES CAPACITY FOR CLINICAL TRIALS AND OFFERS CLIENTS FIRST-OF-ITS-KIND CELL PROFILING CAPABILITIES COMBINING...